Yamashita, Taro

EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma

Yamashita, T., Forgues, M., Wang, W., Kim, J. W., Ye, Q., Jia, H., Budhu, A., Zanetti, K. A., Chen, Y., Qin, L.-X., et al. (2008) · Cancer Research

Hepatocellular Carcinoma Treatment and PrognosisLiver physiology and pathology

Cited by 717

A liver-derived secretory protein, selenoprotein P, causes insulin resistance

Misu, H., Takamura, T., Takayama, H., Hayashi, H., Matsuzawa-Nagata, N., Kurita, S., Ishikura, K., Ando, H., Takeshita, Y., Ota, T., et al. (2010) · Cell Metabolism

Adipokines, Inflammation, and Metabolic DiseasesSelenium in Biological Systems

Cited by 583

Activation of Hepatic Stem Cell Marker EpCAM by Wnt–β-Catenin Signaling in Hepatocellular Carcinoma

Yamashita, T., Budhu, A., Forgues, M., & Wang, X. W. (2007) · Cancer Research

Wnt/β-catenin signaling in development and cancerHepatocellular Carcinoma Treatment and Prognosis

Cited by 446

The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma

Zeng, S. S., Yamashita, T., Kondo, M., Nio, K., Hayashi, T., Hara, Y., Nomura, Y., Yoshida, M., Hayashi, T., Oishi, N., et al. (2014) · Journal of Hepatology

Hepatocellular Carcinoma Treatment and PrognosisCancer Cells and Metastasis

Cited by 140

Differential interferon signaling in liver lobule and portal area cells under treatment for chronic hepatitis C

Honda, M., Nakamura, M., Tateno, M., Sakai, A., Shimakami, T., Shirasaki, T., Yamashita, T., Arai, K., Yamashita, T., Sakai, Y., et al. (2010) · Journal of Hepatology

Hepatitis C virus researchinterferon and immune responses

Cited by 21